X T L Biopharmaceuticals reported $13.6M in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alaunos Therapeutics USD 7M 2M Mar/2026
Bioline Rx USD 12M 4M Dec/2025
Teva Pharmaceutical Industries USD 114.54B 80.27B Jun/2026
X T L Biopharmaceuticals USD 22M 8M Dec/2024